Viking Therapeutics P/E Ratio

Viking Therapeutics (VKTX) currently reports a P/E ratio of -7.12. That is below the Healthcare sector average of 25.93. Use the charts on this page to explore Viking Therapeutics's P/E ratio history and peer comparisons.

Viking Therapeutics's P/E ratio of -7.12 is lower than the Healthcare sector average of 25.93. That is roughly 127.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Viking Therapeutics's market price to a fundamental measure such as earnings, sales, or book value. At -7.12, VKTX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -7.12, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.93. From there, open related valuation or income-statement pages for Viking Therapeutics, and consider following VKTX for alerts when major investors trade the stock.

Viking Therapeutics is classified in the Healthcare sector. On P/E ratio, it currently shows -7.12 versus a sector average near 25.93. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VKTX with unrelated industries.